Loading...
Loading...
Among the 7 tracked institutional investors we monitor, ABCL (AbCellera Biologics Inc.) is held with a combined value of $142.67M across 40,878,720 shares. The largest holder is BAKER BROS. ADVISORS LP with a position worth $105.66M (0.61% of their portfolio). 4 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$142.67M
Total Shares Held
40,878,720
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | $105.66M | 0.61% | +10.0% |
| 2 | BlackRock, Inc. | $14.10M | 0.00% | +4.5% |
| 3 | CITADEL ADVISORS LLC | $6.55M | 0.00% | -15.9% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $5.27M | 0.01% | -36.8% |
| 5 | MILLENNIUM MANAGEMENT LLC | $4.52M | 0.00% | -27.0% |
| 6 | Point72 Asset Management, L.P. | $4.01M | 0.01% | +17.7% |
| 7 | STATE STREET CORP | $2.55M | 0.00% | +5.2% |
As of the latest SEC 13F filings, BAKER BROS. ADVISORS LP is the largest institutional holder of ABCL with a position worth $105.66M, representing 0.61% of their portfolio. In total, 7 institutional investors hold ABCL with a combined value of $142.67M.
Institutional investors hold $142.67M worth of ABCL stock across 7 positions. The largest institutional holder is BAKER BROS. ADVISORS LP with $105.66M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABCL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABCL positions.